Evidence map›Paper›PMID 37626605›Full record

ArticleBiomedicines2023

Robot-Assisted Sacrocolpopexy versus Trans-Vaginal Multicompartment Prolapse Repair: Impact on Lower Bowel Tract Function.

Alessia Martoccia, Yazan Al Salhi, Andrea Fuschi, Onofrio Antonio Rera, Paolo Pietro Suraci, Silvio Scalzo, Alice Antonioni, Fabio Maria Valenzi, Manfredi Bruno Sequi, Cosimo De Nunzio and 11 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Alessia MartocciaUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Yazan Al SalhiUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Andrea FuschiUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Onofrio Antonio ReraUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.ORCID 0000-0003-4684-632X
Paolo Pietro SuraciUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Silvio ScalzoUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Alice AntonioniUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Fabio Maria ValenziUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Manfredi Bruno SequiUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.ORCID 0000-0002-0578-5738
Cosimo De NunzioDepartment of Urology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.ORCID 0000-0002-2190-512X
Riccardo LombardoDepartment of Urology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.
Alessandro SciarraPoliclinico Umberto I, Department of Urology, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-7899-8056
Giovanni Di PierroPoliclinico Umberto I, Department of Urology, Sapienza University of Rome, 00161 Rome, Italy.
Giorgio BozziniDepartment of Urology, ASST Lariana-Sant'Anna Hospital, 22100 Como, Italy.
Anastasios D AsimakopoulosUrology Unit, Fondazione PTV Policlinico Tor Vergata University Hospital, 00133 Rome, Italy.ORCID 0000-0002-7230-579X
Enrico Finazzi AgròUrology Unit, Fondazione PTV Policlinico Tor Vergata University Hospital, 00133 Rome, Italy.
Alessandro ZucchiDepartment of Urology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-2252-4297
Marilena GubiottiDepartment of Urology, San Donato Hospital, 52100 Arezzo, Italy.
Mauro CervigniUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Antonio CarboneUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.ORCID 0000-0003-1725-1933
Antonio Luigi PastoreUrology Unit, Department of Medical-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, 04100 Latina, Italy.
Sapienza University of Rome · ITPoliclinico Tor Vergata · ITPoliclinico Umberto I · ITAzienda Socio Sanitaria Territoriale Lariana · ITOspedale San Donato · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluated the effectiveness, safety, and possible changes in bowel symptoms after multicompartment prolapse surgery by comparing two different surgical approaches, transvaginal mesh surgery with levatorplasty (TVMLP) and robot-assisted sacrocolpopexy (RSC).

methodsAll patients underwent pelvic (POP-Q staging system) and rectal examination to evaluate anal sphincter tone in the lithotomy position with the appropriate Valsalva test. The preoperative evaluation included urodynamics and pelvic magnetic resonance defecography. Patient Global Impression of Improvement (PGI-I) at follow-up measured subjective improvement. All patients completed Agachan-Wexner's questionnaire at 0 and 12 months of follow-up to evaluate bowel symptoms.

resultsA total of 73 cases were randomized into the RSC group (36 cases) and TVMLP group (37 cases). After surgery, the main POP-Q stage in both groups was stage I (RCS 80.5% vs. TVMLP 82%). There was a significant difference (

conclusionsRSC and TVMLP successfully corrected multicompartment POP. RSC showed a greater improvement in the total Agachan-Wexner score and lower bowel symptoms.

Indexed as

lower bowel tract symptomspatient global impression improvementpelvic organ prolapserobotic-assisted sacrocolpopexytransvaginal surgery

Identifiers

PMID37626605
PMCPMC10452351
OpenAlexW4385307795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.